Garlic.
Research-backed compound with potential health benefits. Garlic's sulfur compounds support normal relaxation of blood vessels, and they're studied for keeping blood pressure and cholesterol that already sit in the normal range where they are.
Reviewed March 2026
- Category
- Compound
What Garlic is, and what it does.
- Does it work
- It suits people building a heart and circulation routine, and anyone who rarely cooks with the fresh bulb. With 53,880 published records behind it, few plants are studied this heavily.
- How much to take
- Start with 600mg to 1,200mg a day of a standardised preparation, with food. That band is where garlic's sulfur chemistry does its everyday work. 2,400mg is a research condition.
- Time to feel it
- Give it four to twelve weeks. Changes land on a blood pressure cuff or a lipid panel rather than in how the day feels, so a repeat reading is where you see them.
- The first dose
- Day one is mostly taste and breath. The sulfur chemistry gets going within seconds of crushing, but its effects register on a panel over weeks.
- With regular use
- Weeks of daily use are where readings already in the normal range get studied, and most trials read their blood pressure and lipid outcomes between four and twelve weeks.
- How well tolerated
- Well tolerated. It slows platelet clumping, so tell your doctor if you take blood thinners or have surgery booked, and take it with food if it repeats on you.
- How it feels
- You notice the breath and a warm taste more than anything else. The circulation effects are quiet and show up in numbers your doctor reads.
- The overlooked benefit
- Crush a clove and let it stand ten minutes before it meets heat. That gap lets the enzyme finish making allicin, so more of the sulfur chemistry survives the pan.
600 to 1,200mg a day is where Garlic works.
Source: Ried 2016 blood pressure meta + Josling 2001 cold study
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Garlic is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- blood pressure already in the normal rangeMeta-analysis
- cholesterol already in the normal rangeMeta-analysis
- platelet aggregation markersRandomised trial
- seasonal immune resilienceRandomised trial
- antioxidant statusIn vitro study
- hydrogen sulfide signalling in vascular smooth muscleAnimal study
Questions people ask about Garlic.
- When should I take it?
- Morning for energy-related benefits, evening for calming ones. Take with food to reduce any stomach upset.
- How long until I notice something?
- Most people notice something within 2-4 weeks. Full effects usually take 6-8 weeks. Be patient.
- Should I cycle it?
- Not strictly necessary for most herbs, but a 1-week break every 2-3 months isn't a bad idea. Keeps your body responsive.
- Any drug interactions I should know about?
- Always check with your pharmacist before combining with prescription meds. Herbs can affect how your liver processes drugs, sometimes in surprising ways.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Garlic's organosulfur compounds and ginkgo both dampen platelet aggregation through separate pathways, so taken together they nudge the body's normal clotting process further in the same direction. Anyone already managing their clotting should keep this additive effect in mind.
Both garlic and the omega-3 fatty acids in fish oil mildly reduce platelet stickiness, so the effect on normal blood clotting stacks when they are combined. This is settled pharmacology rather than a claim about either one alone.
Garlic organosulfur compounds and the hydrogen sulfide they release raise endothelial nitric oxide synthase activity. Arginine is the substrate that enzyme converts into nitric oxide, so activity and supply pair up.
Ascorbate maintains tetrahydrobiopterin in the reduced form nitric oxide synthase requires and slows the reaction of nitric oxide with superoxide. That supports the same endothelial step garlic acts on.
Garlic organosulfur compounds release hydrogen sulfide through reactions with cellular thiols, and cysteine is the main source of those thiols. NAC keeps the cysteine and glutathione pool that the conversion draws on topped up.
Garlic grown in selenium-rich soil accumulates selenium in methylated forms analogous to its sulfur compounds, and both are handled by the same methyltransferase steps. That shared chemistry is the basis for formulating the two together.
Sulfur compounds from garlic and onion increase the soluble fraction of non-heme iron in a meal, an effect measured repeatedly in food matrix work. That runs opposite to the chelating effect of polyphenols.
The same garlic sulfur compounds that help iron also raise the bioaccessible fraction of zinc from a mixed meal. Sulfur ligands appear to keep the mineral soluble through the small intestine.
Monacolin K inhibits HMG-CoA reductase directly, while garlic organosulfur compounds have been reported to reduce the activity of that same enzyme by a separate route. They act on one pathway from two angles, so dose stacking should be considered.
Gingerols reduce thromboxane synthesis while garlic organosulfur compounds reduce platelet aggregation by their own route. The two effects on normal clotting add together.
Curcumin dampens platelet activation through thromboxane and calcium signalling, in the same direction as garlic. Stacking them moves normal clotting further than either alone.
High-dose tocopherol reduces platelet adhesion and, at large intakes, interferes with vitamin K-dependent clotting factor activity. Combined with garlic the effect on normal clotting is additive.
EPA displaces arachidonic acid from platelet membranes and shifts thromboxane output, and garlic reduces aggregation separately. Both together are worth flagging around surgery or anticoagulant medicine.
Garlic preparations are studied mainly for circulating lipid and blood pressure measures, while CoQ10 sits in the mitochondrial electron transport chain and in circulating lipoproteins as a lipid-phase antioxidant. The two are combined for coverage of different targets rather than because one changes the other. No combination trial is cited here.
Adequate potassium intake supports normal blood pressure through renal sodium handling and vascular smooth muscle polarisation. Garlic has been studied for the same measure by a different route involving hydrogen sulfide signalling and nitric oxide availability. Because both are aimed at the same measure, anyone already managing blood pressure with a clinician should have both on the record; the combined size of any effect has not been measured.
Magnesium acts as a physiological calcium antagonist in vascular smooth muscle and supports normal vessel tone. Garlic is studied for the same endpoint through nitric oxide and hydrogen sulfide pathways. The routes are separate, so the measure can move from both directions at once.
Citrulline is converted to arginine in the kidney and raises the substrate pool for endothelial nitric oxide synthase. Garlic-derived polysulfides are described as increasing nitric oxide availability by a different step involving hydrogen sulfide crosstalk. Both feed the same vasodilatory signal, which is why they appear in the same formulas.
Dietary nitrate is reduced to nitrite by oral bacteria and then to nitric oxide in tissue, a route independent of nitric oxide synthase. Garlic acts on the enzymatic side. Combining them stacks two entry points into the same signalling molecule, and anyone tracking blood pressure should count both.
Garlic constituents reduce platelet aggregation in laboratory and human work, and nattokinase is a fibrinolytic enzyme preparation. Two agents acting on different parts of haemostasis can add up. This pairing belongs on a clinician's radar rather than in a stack assembled without one.
Salicin from willow bark is converted to salicylate, which inhibits platelet cyclooxygenase. Garlic reduces platelet aggregation through a separate, non-cyclooxygenase route. The effects on the same function can combine, so this is a flag rather than a recommendation.
Quercetin occurs naturally in onions and other alliums and is often supplied alongside garlic in whole-food formulas. Both have been described as acting on endothelial and inflammatory signalling in laboratory work. Human evidence for the pair specifically is not established.
Resveratrol has been studied for endothelial function markers and garlic for blood pressure and lipid measures. They are combined for breadth across the same physiological area. No trial measures them together.
Taurine is abundant in cardiac tissue and is involved in calcium handling and osmoregulation there. Garlic is studied for vascular measures upstream of the heart. The pairing covers two parts of the same system rather than acting on one target together.
Berberine has human data on glucose and lipid markers through AMPK and LDL receptor pathways. Garlic has pooled trial data on glycaemic and lipid markers by other routes. Anyone tracking blood sugar should count both, because the measure can move from either.
Chromium is involved in insulin receptor signalling and is supplied where normal glucose handling is the goal. Garlic has been reviewed for glycaemic markers in adults. Two ingredients aimed at the same measure should be counted together rather than assumed independent.
Catechins and organosulfur compounds act on different oxidative and lipid handling steps but are placed in the same cardiometabolic formulas. Each has its own human literature; the combination does not. Read it as formulation practice.
Fresh garlic is naturally rich in inulin-type fructans, which pass undigested to the colon and are fermented by resident bacteria. Adding supplemental inulin increases the same substrate pool. This also explains why whole garlic powder can be poorly tolerated by people sensitive to fermentable carbohydrates.
Vitamin D3 and garlic appear together in general wellness and seasonal-support products. Their mechanisms do not overlap: one is a secosteroid acting through a nuclear receptor, the other a set of reactive organosulfur compounds. Count the pairing as formulation rather than interaction.
Nothing specific on file for Garlic. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Garlic actually does.
Whole garlic keeps alliin and the enzyme alliinase in separate compartments. Crush or chew a clove and the two meet, and alliin gets converted to allicin within seconds.
Allicin is unstable and breaks down into a family of sulfur compounds including diallyl disulfide, diallyl trisulfide, ajoene and vinyldithiins, so what actually reaches your body depends on how the bulb was processed.
Heat and stomach acid both denature alliinase for good, which is why cooked garlic and non-enteric powders give you less allicin than freshly crushed raw material.
Ageing garlic in water and ethanol over months turns the unstable thiosulfinates into water-soluble compounds like S-allyl cysteine. You end up with a different mix of constituents and far less odour.
Where Garlic comes from.
It all starts as ordinary garlic bulbs. What you get depends on what happens next: gentle drying keeps the enzyme that makes allicin, long ageing in alcohol makes a milder odourless extract, and steam distillation makes an oil. These are not interchangeable, so the form on the label matters.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Cultivated garlic bulbs, cured after harvest to reduce moisture in the outer skins. China supplies the large majority of the world crop, with Spain, Argentina and the United States as other volume sources.
Everything downstream depends on the choice here. Slicing and low-temperature drying preserves alliin and alliinase; steam distillation destroys both and yields volatile sulfides; extended ageing in aqueous ethanol converts the thiosulfinates to water-soluble compounds; maceration in oil produces yet another set.
Dried material is milled to powder. Distillate is collected and diluted into carrier oil. Aged material is filtered and concentrated after its ageing period.
Aqueous extracts are filtered and concentrated under reduced pressure; oils are clarified and standardised for sulfide content.
Powders are assayed for allicin yield under a defined test, aged extracts for S-allyl cysteine, oils for diallyl disulfide and trisulfide. The marker chosen is dictated by the process, since no single marker fits all garlic forms.
Powders are tabletted and enteric coated to protect alliinase from gastric acid; oils and aged liquid concentrates go into softgels or liquid formats.
Getting Garlic from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across 20 trials in 970 people, garlic supplements lowered systolic blood pressure by about 5 mmHg on average and by close to 9 mmHg among those with raised readings at baseline.Meta-analysis. Ried, 2016 (The Journal of Nutrition). PMID 26764326 ↗
- Pooling the randomized trials, garlic powder lowered total cholesterol by about 16 mg/dL and LDL cholesterol by about 8 mg/dL.Meta-analysis. Kwak et al., 2014 (Nutrition Research and Practice). PMID 25489404 ↗
- Across seven randomized trials in 513 people, garlic intake lowered fasting blood glucose (standardized mean difference -1.67).Meta-analysis. Hou et al., 2015 (Asia Pacific Journal of Clinical Nutrition). PMID 26693740 ↗
- Pooling 108 randomised trials in 7,137 adults, garlic lowered total cholesterol by about 10 mg/dL, systolic blood pressure by 3.7 mmHg, diastolic by 2.0 mmHg and fasting blood glucose by 2.8 mg/dL, and raised HDL cholesterol by 2.2 mg/dL.Meta-analysis. Behrouz et al., 2026 (Nutrition Reviews). PMID 40580481 ↗
- Across 19 trials, aged garlic lowered systolic blood pressure by 2.5 mmHg and LDL cholesterol by 4.4 mg/dL, with no detectable change in diastolic pressure or HDL cholesterol.Meta-analysis. Bashiri et al., 2025 (Phytotherapy Research). PMID 40628369 ↗
- Across 17 randomised trials, garlic lowered the inflammation marker C-reactive protein, and aged garlic extract lowered both C-reactive protein and TNF alpha, while interleukin 6 showed no detectable change.Meta-analysis. Mirzavandi et al., 2020 (Diabetes and Metabolic Syndrome). PMID 32673835 ↗
- Pooling 6 trials in 301 people, garlic lowered the liver enzyme AST, a marker rather than an outcome, by a small amount (Hedges' g -0.36), with no detectable change in ALT.Meta-analysis. Panjeshahin et al., 2020 (Phytotherapy Research). PMID 32135032 ↗
- Of 12 randomised trials covering 595 participants, 6 reported less platelet clumping with garlic, and the reviewers judged the trials too few and too varied to pool, so the size of the effect on platelet function stays unsettled.Systematic review. Mollahosseini et al., 2022 (Phytotherapy Research). PMID 36222178 ↗
- Pooled randomised trials reported changes in several clustered cardiometabolic measures with garlic supplementation, with the usual heterogeneity between preparations and doses.Meta-analysis. Fu et al., 2023 (BMC Complementary Medicine and Therapies). PMID 37481521 ↗
- Randomised trials of garlic supplementation were pooled for effects on circulating serum measures; the review reports marker change, not a clinical endpoint.Meta-analysis. Shekarchizadeh-Esfahani et al., 2021 (International Journal of Clinical Practice). PMID 33792129 ↗
- Pooled randomised trials in adults with impaired liver markers reported changes in circulating liver enzyme values; enzymes are markers and the pooled trials were small.Meta-analysis. Xiaohui et al., 2023 (African Health Sciences). PMID 38223588 ↗
- Garlic supplementation reduced markers of exercise-induced oxidative and inflammatory response, while the trial failed to detect a difference in cycling time-trial performance.Randomised trial. Tsao et al., 2023 (Journal of the International Society of Sports Nutrition). PMID 37170623 ↗
- An acute garlic dose was tested against fibrinolytic and vasoreactive responses to exercise; the report describes short-term vascular and clotting-related measures, not longer-term outcomes.Randomised trial. Womack et al., 2015 (Journal of the International Society of Sports Nutrition). PMID 26019694 ↗
- Garlic supplementation was associated with shorter intestinal transit time and changes in lipid accumulation product and other cardiometabolic indices in this randomised trial.Randomised trial. Sangouni et al., 2023 (Phytotherapy Research). PMID 36721177 ↗
- Twelve weeks of garlic supplementation was compared with control on self-reported joint comfort and mobility scores in women carrying excess body weight; scores are subjective endpoints in a single trial.Randomised trial. Salimzadeh et al., 2018 (International Journal of Clinical Practice). PMID 29790635 ↗
- Garlic supplementation was tested against clustered metabolic measures in adult women with a hormonal-metabolic presentation; a single randomised trial reporting markers.Randomised trial. Hesari et al., 2025 (Journal of Health, Population and Nutrition). PMID 40770379 ↗
- A secondary analysis reported associations between lifestyle factors, vitamin and garlic supplementation and long-term gastric outcomes; an association in a secondary analysis, not a demonstrated cause.Cohort study. Guo et al., 2020 (JAMA Network Open). PMID 32589229 ↗
- A long-running factorial randomised trial with more than two decades of follow-up reported gastric outcomes across vitamin and garlic supplementation arms; the garlic arm's result is one factor within a multi-arm design.Randomised trial. Li et al., 2019 (BMJ). PMID 31511230 ↗
These are the studies our verdict leans on, chosen from the 218 we read for Garlic. The full linked list is below.
The studies, linked.
12 sources behind our Garlic verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialAn Exploratory Eighteen Month Clinical Study To Evaluate Efficacy Of AGE Product On Periodontitis, A Dose Response StudyClinicalTrials.gov ↗NA · 300 participants · Completed
- Clinical trialAtherosclerosis Monitoring and Atherogenicity Reduction StudyClinicalTrials.gov ↗PHASE3 · 300 participants · Completed
- Clinical trialEffect of Aged Garlic Extract (AGE) on Progression of Coronary Atherosclerosis in Persons With Type 2 Diabetes MellitusClinicalTrials.gov ↗NA · 88 participants · Completed
- Clinical trialEffects of Monascus Garlic Fermented Extract on Serum Triglyceride Level: a Double-Blind, Randomized Controlled TrialClinicalTrials.gov ↗NA · 55 participants · Completed
- Clinical trialDouble-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for HypertensionClinicalTrials.gov ↗NA · 43 participants · Completed
- Clinical trialEffect of Garlic Extracts on Changes in Cerebral Blood Flow: Randomized, Double-blind, Placebo-controlled StudyClinicalTrials.gov ↗NA · 30 participants · Completed
- Clinical trialEffect of Garlic Extracts on Changes in Blood Flow Velocity in the Carotid Artery: Randomized, Double-blind, Placebo-controlled StudyClinicalTrials.gov ↗NA · 30 participants · Completed
- Clinical trialIdentification of the Antiplatelet Compounds of Garlic Ex VivoClinicalTrials.gov ↗NA · 9 participants · Completed
- Clinical trialA Pilot Study to Evaluate the Influence of Garlic on the Pharmacokinetics of Docetaxel in Patients With Metastatic Breast CancerClinicalTrials.gov ↗NA · Completed
- Clinical trialPlacebo-Control, Randomized, Double Blind Long Term Trial to Evaluate the Efficacy of Garlic Product on PeriodontitisClinicalTrials.gov ↗NA · 200 participants · Unknown
- Clinical trialA Controlled Study to Determine The Clinical Efficacy Of Garlic Compounds In Patients With Chemotherapy Related Febrile NeutropeniaClinicalTrials.gov ↗PHASE1 · 120 participants · Unknown
- Clinical trialEvaluation of Antimicrobial Potency of Garlic Lemon Extract Irrigant Versus Physiological Saline Irrigant Following Partial Pulpectomy in Primary Molars: A Randomized Clinical TrialClinicalTrials.gov ↗NA · 38 participants · Not yet recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 117,483 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Garlic is, not how risky it is. A report is not proof Garlic caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.



